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Cellular/Molecular
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Integrins are involved in axon growth and regeneration. Manipulation of integrins is a route to promoting axon regeneration and
understanding regeneration failure in the CNS. Expression of 9 integrin promotes axon regeneration, so we have investigated 91
trafficking and transport in axons and at the growth cone. We have previously found that9 and1 integrins traffic via Rab11-positive
recycling endosomes inperipheral axons andgrowth cones.However, transport viaRab11 is slow,while rapid transport occurs in vesicles
lacking Rab11. We have further studied 9 and 1 integrin transport and traffic in adult rat dorsal root ganglion axons and PC12 cells.
Integrins are in ARF6 vesicles during rapid axonal transport and during trafficking in the growth cone. We report that rapid axonal
transport of these integrins and their trafficking at the cell surface is regulated byARF6. ARF6 inactivation by expression of ACAP1 leads
to increased recycling of 1 integrins to the neuronal surface and to increased anterograde axonal transport. ARF6 activation by
expression of the neuronal guanine nucleotide exchange factors, ARNO or EFA6, increases retrograde integrin transport in axons and
increases integrin internalization. ARF6 inactivation increases integrin-mediated outgrowth, while activation decreases it. The coordi-
nated changes in integrin transport and recycling resulting fromARF6 activation or inactivation are the probablemechanismbehind this
regulation of axon growth. Our data suggest a novel mechanism of integrin traffic and transport in peripheral axons, regulated by the
activation state of ARF6, and suggest that ARF6 might be targeted to enhance integrin-dependent axon regeneration after injury.
Introduction
Integrins are a large family of transmembrane proteins that func-
tion as receptors for extracellular matrix molecules. They have
functions in both the developing and mature nervous system,
with roles in neurite outgrowth, synaptic plasticity, and periph-
eral nerve regeneration (Werner et al., 2000; Brakebusch and
Fa¨ssler, 2005; Gardiner et al., 2005, 2007;Webb et al., 2007; Lin et
al., 2008; Plantman et al., 2008;McGeachie et al., 2011;Myers and
Gomez, 2011). Integrins exist as heterodimers, composed of an
- and a -subunit, with the specificity for their ligands being
governed by the combined properties of both subunits. In our
studies on spinal cord injury, we have focused on the integrin
91, because it is a receptor for tenascin-C, amatrix protein that
is present in the adult CNS and upregulated after injury (Tang et
al., 2003).We have reported that exogenous91 expression can
enhance sensory axon regeneration into the spinal cord (An-
drews et al., 2009). However, as integrin transport is restricted in
some CNS axons, we have also studied 91 trafficking. In a
previous paper we demonstrated an integrin recycling pathway
via Rab11-positive recycling endosomes, which can be manipu-
lated to enhance axon growth (Eva et al., 2010). While much of
the integrin in axons was found in Rab11-positive vesicles, we
noted that integrin undergoing rapid long-range movement was
not associated with Rab11. We hypothesized that the carrier for
rapid transport might be ARF6. ARF6 is another GTPase present
on recycling endosomes, and it is reported to function together
with Rab11 in the recycling of integrins and during cytokinesis
(Hickson et al., 2003; Powelka et al., 2004; Fielding et al., 2005;
Inoue et al., 2008). ARF6 is present in neurons in the CNS where
it is involved in axonal and dendritic development and dendritic
spine morphology (Herna´ndez-Deviez et al., 2002, 2004; Mi-
yazaki et al., 2005; Choi et al., 2006), but there is no literature
regarding its role in neuronal integrin traffic.
As in our previous work, we have investigated the trafficking
of 9 and 1 integrins in adult dorsal root ganglion (DRG) neu-
rons and PC12 cells, and report that integrins traffic and trans-
port in these cells via ARF6.
We have investigated the regulation of integrin transport and
trafficking through manipulation of ARF6 activity using the
overexpression of ACAP1, an ARF6 GTPase activating protein
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(GAP), and two neuronal ARF6 guanine nucleotide exchange
factors (GEFs) EFA6 andARNO. Inactivation of ARF6 byACAP1
enhances axon growth, externalization of integrin, and antero-
grade integrin transport, while activation of ARF6 using EFA6
and ARNO reduces axon growth and increases integrin internal-
ization and retrograde integrin transport. Our data therefore de-
scribe a novel role for ARF6 in the regulation of integrin traffic
and transport in peripheral axons and suggest that ARF6 might
be targeted to enhance integrin-dependent outgrowth during re-
generation after injury.
Materials andMethods
DNAconstructs. Integrin9 enhancedgreen fluorescent protein (EGFP)-N3
was obtained fromAddgene (plasmid 13600), deposited by Dean Sheppard
(University of California, San Francisco, CA), and has been described previ-
ously (Eva et al., 2010). pXS-HA-ARF6 (Radhakrishna et al., 1996),
pcDNA3.1-ACAP1-myc (Li et al., 2007b), and pFLAG-CMV2-ACAP1-
R448Q (Jackson et al., 2000)were all gifts fromDr.VictorHsu (Department
ofMedicine, HarvardMedical School, Boston,MA). pcDNA3-ARF6-Q67L
and pcDNA3-ARF6-T27N (Peters et al., 1995; Furman et al., 2002) were
obtained fromAddgene (plasmid10835and10831, respectively) anddepos-
ited by Thomas Roberts/Richard Klausner (Harvard Medical School, Bos-
ton,MA).pFLAG-CMV6-EFA6(Brownet al., 2001)was agift fromDr. Julie
Donaldson (NationalHeart Lung andBlood Institute,National Institutes of
Health, Bethesda, MD). EFA6 cDNA was obtained by PCR amplification
using pFLAG-CMV6-EFA6 as a template and was digested with EcoRI and
SalI and cloned into the same sites of pEGFP-C1 (Clontech) to obtain
pEGFPC1-EFA6. pEGFPC1-ARNO construct was described previously
(Venkateswarlu et al., 1998). The ARNO cDNA released from pBTM116-
ARNO (Venkateswarlu, 2003) by EcoRI and SalI digestion was cloned into
the same sites of pCMV-FLAG2B (Stratagene) to obtain pCMV-FLAG2B-
ARNO. pSNAP-ARF6 was generated by cloning full-length human ARF6,
amplified by PCR from pARF6-CFP (obtained from Addgene; plasmid
11382), and deposited by Joel Swanson into the pSNAPmvector (NewEng-
land Biolabs) EcoR1 site.
Antibodies. Antibodies against ARF6 were obtained from Abcam:
ab77581 was used for immunofluorescence and ab49931 was used for
Western blotting. Directly conjugated Alexa Fluor 488 or 647 anti-
mouse/rat CD29 (integrin 1) antibody (clone HM1-1; BioLegend)
was used for detecting 1 integrin on fixed cells and also for live labeling
and imaging. 1 integrin was detected on Western blots using the anti-
body AB1952 (Millipore). AB1952 was also used for ELISA capture of
biotinylated1 integrin for the internalization and recycling assays. Cap-
tured biotinylated1 integrinwas detectedwith streptavidin-conjugated
horseradish peroxidase (HRP) (Vector Laboratories). KDEL was de-
tected with anti-KDEL clone 10C3 (Abcam), GM130 with polyclonal
anti-GM130 (BD Biosciences Transduction Laboratories), and Rab11
with anti-Rab11 from Invitrogen (Zymed). -actin was detected using
the antibody AC-15 (Abcam). Hemagglutinin (HA) tag was detected
with anti-HA clone 16B12 (Covance), FLAG epitope with Abcam
ab182390, and myc with anti-myc clone 9E10 (Santa Cruz Biotechnol-
ogy). 91 integrin function was blocked with anti-91 clone Y9A2
(Abcam). Fluorescent secondary antibodies were Alexa conjugates from
Invitrogen used at 1:800. HRP-conjugated secondary antibodies for
Western blotting were from GE Healthcare.
Dissociated adult rat DRG cultures. Adult male Sprague Dawley rats
were killed and DRGs were removed. DRGs were incubated with 0.1%
collagenase inDMEM for 90min at 37°C followed by 10min in trypsin at
37°C. DRGs were dissociated by trituration in a blunted glass pipette.
Dissociated cells were then centrifuged through a layer of 15% bovine
serum albumin (BSA), washed in DMEM, and cultured on 1 g/ml
laminin, on poly-D-lysine-coated acid-washed coverslips in DMEM sup-
plemented with 10% fetal calf serum (Invitrogen), 1% penicillin/strep-
tomycin, and 30 ng/ml nerve growth factor (NGF).
PC12 cell culture. Low passage number PC12 cells were cultured as
previously described (Eva et al., 2010), routinely grown in RPMI 1640
media (Sigma-Aldrich), and supplemented with 10% batch-tested
French fetal bovine serum (Biosera), 1% penicillin/streptomycin, and 2
mM L-glutamine on flasks coated with type IV collagen (Sigma-Aldrich).
For differentiation to a neuronal phenotype, PC12 cells were primed at
low density in the usual culturemedia supplemented with 50 ng/ml NGF
(Sigma-Aldrich) for 10 d and stored at 80°C or used immediately.
Primed PC12 cells were differentiated in the usual media supplemented
with 50 ng/ml NGF (Sigma-Aldrich) and analyzed after 2 d. Cells were
therefore analyzed a total of 12 d after treatment with NGF. PC12 cells
stably expressing 9 integrin have been described previously (Eva et al.,
2010), and were grown in the same conditions as wild-type (wt) PC12
cells, except when used for the 9 integrin-specific neurite outgrowth
assay. PC12 cells stably expressing ARF6-SNAP were generated by elec-
troporation followed by selection with 400 g/ml neomycin (G418; In-
vitrogen). Nonclonal lines were generated, as the ARF6-SNAP vector
contains the neomycin resistance gene on an internal ribosomal entry site
cassette.
Analysis of 9 integrin-dependent neurite outgrowth. To analyze 9
integrin-dependent neurite outgrowth, PC12 cells stably expressing 9
integrin were grown on a substrate of tenascin, as described previously
(Eva et al., 2010). PC12 cells were primed as described above, and after
10 d in the presence of NGF, cells were trypsinized and electroporated
with either DNA constructs or mock transfected as a control. Cells were
then plated onto 24-well culture plates coated with 5 g/ml tenascin
(Millipore) and grown for two 2 d in the usual differentiation media but
without antibiotics. All cells were additionally cultured in the presence of
the 91 blocking antibody Y9A2 (Abcam) at 1:300, a concentration we
previously determined as generating a partial block of function. Cells
were then fixed and labeled to identify the epitope tag and analyzed in situ
either by phase contrastmicroscopy or by virtue of the fluorescent signal.
Neurite outgrowth analysis was performed 2 d after plating in differen-
tiationmedia (a total of 12 d in the presence of NGF). Neurite outgrowth
was analyzed using a Leica DM6000 microscope and Leica LAS AF soft-
ware to measure the length of neurites in micrometers. The longest neu-
rites of 50 cells were measured per condition. Four wells were analyzed
per experiment, and three experiments were performed. GraphPad
Prism was used for statistical analysis of data.
Transfection of dissociated adult DRG neurons for analysis of axon
growth.DRG neurons were removed and dissociated as described above.
Cells were transfected with plasmid DNA encoding GFP- or epitope-
tagged constructs or transfected with plasmid DNA encoding GFP alone
as a control. Transfection was achieved using a Microporator (Invitro-
gen). Approximately 1  105 cells were transfected per reaction in a
volume of 10 l. Transfected cells were plated and cultured as described
above, but without antibiotics. Axon length was analyzed after 48 h in
culture. Cells were fixed and labeled and viewed with a Leica DM6000
microscope, and Leica LAS AF software was used to trace and measure
the length of axons in micrometers. The longest axon of all transfected
cells wasmeasured for each experiment. Between 35 and 98 neuronswere
analyzed per condition per experiment. On average, 60 neurons were
analyzed per condition. GraphPad Prism was used for statistical analysis
of data.
Transfection of dissociated adult DRG neurons for live imaging experi-
ments. Adult DRG neurons were dissociated and cultured as described
above on glass-bottom imaging dishes (MatTek) for 24 h before being
transfected using a Cellaxess in-dish electroporator (Cellectricon). In
this way, neurons had already extended axons before they expressed the
transfected constructs. Cells were transfected with 9 integrin-GFP, ei-
ther alone or cotransfected with the indicated epitope-tagged constructs.
In preliminary experiments performed to test the cotransfection effi-
ciency, 100% of 9-GFP-expressing neurons also expressed the cotrans-
fected epitope-tagged construct (determined after fixing and antibody
labeling).
Analysis of ARF6-SNAP vesicle dynamics in neurites. To analyze the
dynamics of ARF6 vesicles within neurites, PC12 cells stably expressing
ARF6-SNAP were primed and differentiated for a total of 12 d as de-
scribed above, so that they had a mature neuronal phenotype, with
lengthy processes. These were grown on collagen-coated glass-bottom
imaging dishes (MatTek), and loaded with SNAP-cell TMR-Star dye
(New England Biolabs) (which has an emission peak of 580 nm), to
identify ARF6-positive structures. Control experiments were also per-
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formed using untransfected cells or transfected cells treated with the
SNAP blocking reagent (NEB) to ensure that the dye was binding specif-
ically to ARF6-SNAP. Cells were labeled for 30 min, washed three times,
and left for 30min to allow unbound dye to leave the cells before washing
again. To identify ARF6 vesicles containing endogenous 1 integrins,
cells were additionally labeled with anti 1–488 (BioLegend) for 1 h and
washed three times before imaging. Cells were imaged using spinning
disk confocal microscopy, with an Olympus IX70 microscope, a
Hamamatsu EM-CCD Image-EM camera, and a PerkinElmer Ultra-
VIEW scanner, controlled with MetaMorph software. Images were
acquired every 3 s. Kymographs were generated using MetaMorph soft-
ware. ARF6 vesicle dynamics were quantified using the methods we have
previously described for analyzing Rab11 or 9-GFP vesicle dynamics
(Eva et al., 2010). Instantaneous velocity was calculated using Meta-
Morph software to measure the distance moved by a vesicle between two
consecutive frames. Vesicles were tracked for their visible lifetime, and
the maximum distance moved between two frames was measured and
used to calculate instantaneous speed. Both anterograde and retrograde
vesicles were included for analysis (as for Rab11 or 9-GFP previously).
Bidirectional and immobile vesicles were not included for quantification,
counting moving vesicles as anything moving faster than 0.5 m/s. The
distance covered by vesicles over timewasmeasured as themaximumnet
distance a vesicle moved10 frames (30 s). Thirty-nine neurite lengths
containing 318 vesicles were analyzed from a total of five experiments.
Velocitieswere binned into 0.2m/s, anddistancewas binned into 1m.
DRG live imaging and analysis of axon transport.DRGneurons express-
ing 9-GFP (either alone or in the presence of an epitope-tagged ARF6
regulatory protein, as indicated) were imaged in glass-bottom dishes
using live spinning disk confocal microscopy, as described above, and
analyzed using MetaMorph software. Axonal vesicles were analyzed to
determine the proportion of mobile and immobile vesicles and the pro-
portion of mobile vesicles moving anterograde, retrograde, or bidirec-
tionally. Vesicles with a total movement of 2 m during their visible
lifetimes were classed as immobile. Vesicles moving in both directions
but with net movement of 2 m (during their visible lifetimes) were
classed as bidirectional, even though total movement may have been
larger. Vesicles with net movements 2 m in either direction (by the
end of their visible lifetimes) were classed as anterograde or retrograde
accordingly.
Instantaneous velocity of anterograde and retrograde vesicles was
quantified as described above. Average velocity was also measured. This
was quantified as the net distance moved by a vesicle during its visible
lifetime, divided by the amount of time for which it was tracked. One
hundred fifty-two neurite lengths containing 2325 vesicles were analyzed
in total, from three individual experiments. One experiment used DRG
cultures generated from a single animal, plated onto five imaging dishes
for transfection with the various indicated DNA constructs, so that each
condition could be investigated in neurons taken from the same animal.
Data were analyzed using GraphPad Prism.
Microscopy. Three microscopes were used in this study, as has been
indicated. Laser scanning confocal microscopy was performed using a
LeicaDMI4000Bmicroscope, with laser scanning and detection achieved
by a Leica TCS SPE confocal system controlled with Leica LAS AF soft-
ware. Standard fluorescent microscopy was performed using a Leica
AF7000 with a Hamamatsu EM CCD C9100 camera and Leica LAS AF
software. Live-cell imaging was performed with an Olympus IX70 micro-
scope using a Hamamatsu EM-CCD Image-Em camera and a PerkinElmer
UltraVIEW scanner for spinning disk confocal microscopy controlled with
MetaMorph software.
Subcellular fractionation. This was performed as previously described
(Eva et al., 2010). Briefly, PC12 cells were differentiated for 12 d. Cells
were homogenized through a 21 gauge needle in detergent-free homog-
enization buffer (250 mM sucrose, 3 mM imidazole, 1 mM EDTA and
protease inhibitors, pH 7.4) and a postnuclear supernatant (PNS) was
generated. The PNS was adjusted to 40.6% sucrose in 3 mM imidazole, 1
mM EDTA, pH 7.4. This was then loaded on the bottom of an ultraclear
SW55 TI centrifuge tube (Beckman Coulter) and overlaid sequentially
with 1.5 ml of 35% sucrose and 1ml of 25% sucrose, and filled to the top
with 1.5 ml homogenization buffer. This was centrifuged at 130,000 g for
1.5 h at 4°C using an SW55 TI rotor (Beckman Coulter). After centrifu-
gation, gradients were collected from top (fraction 1) to bottom (fraction
8). Protein concentration at each fraction was determined using BCA
protein assay (Pierce). Equal volumes from each fraction were analyzed
by Western blotting.
1 integrin internalization and recycling assays.Thismethodwas estab-
lished previously (Roberts et al., 2001; Pellinen et al., 2006; Arjonen et al.,
2012). First, two1 integrin antibodies, cloneHM1–1 (BioLegend) and
AB1952 (Millipore), were tested for capture ELISA specificity by bioti-
nylating the surface of cells, lysing them, and performing immunopre-
cipitationwith either antibody, and running the lysate on aWestern blot,
for detection by streptavidin-HRP. Both antibodies generated a specific
1 integrin band. These antibodies were then titrated for the ELISA assay
to determine optimum antibody concentration, and AB1952 was chosen
for use at 1:200. ELISA plates were coated with this antibody overnight
(1:200; 50 l per well in 0.05 M Na2CO3 pH9.6 at 4°C), and blocked for
1 h (5% BSA in PBS with 0.1% Tween 20) before loading with lysate. For
the internalization assay, PC12 cells were differentiated for 10 d and
electroporated with ARF6 regulatory proteins as indicated, or mock
transfected as a control, and grown in standard differentiationmedia in 6
cm culture plates for 2 d to allowmaximum expression of the transfected
constructs. The cells were placed on ice and washed with ice-cold PBS.
The cell surface was then labeled with 380g/ml EZ-link sulfo-NHS-SS-
biotin (Thermo Scientific) in ice-cold PBS for 30 127 min at 4°C, and
unbound biotin was removed with two washes of ice-cold PBS. Prewarmed
media was then added to cells, and they were placed at 37°C for 30 min, to
allow internalization tooccur.Cellswere thenplaced immediatelyon ice and
washed with cold PBS. Biotin remaining at the cell surface after internaliza-
tionwas removedwith 60mM sodium2-mercaptoethanesulfonate (MesNa;
Sigma) in reduction buffer (50 mM Tris pH 8.6, 100 mM NaCl) for 30 127
min on a rocker at 4°C followed by quenching with 100mM iodoacetamide
(Sigma) for 127 10min, leaving only internalized biotin inside the cells. This
step was omitted from one dish to allow for quantification of total biotin
load, so that the relative amounts of biotinylated internalized integrins were
normalized to the biotin signal of all labeled integrins. Cells were then lysed
in radioimmunoprecipitation assay buffer, cleared by centrifugation, and
the lysate loaded on to the precoated ELISA plate for 2 h. Plates were then
washed, labeled with secondary streptavidin HRP (Vector Laboratories) for
1 h, and visualized with o-phenylenediamine dihydrochloride (OPD;
Thermo Scientific) according to manufacturer’s instructions. Absorbance
was thenmeasured at 490nm. For the recycling assay, biotinylated cellswere
incubated similarly at 37°C for 30min to allow the internalization of biotin-
labeled integrins, and surfacebiotinwas again cleavedwith60mMMesNaon
ice and quenched with 100 mM iodoacetamide (Sigma) for 10 min on ice.
One plate per condition was then kept on ice (time 0), while others were
placed in prewarmed media and incubated at 37°C to allow recycling to
occur.Disheswere thenmovedback to4°Cafter5, 10,or15minat37°C, and
surface biotin was removedwith 60mMMesNa on ice. Cells were then lysed
and biotinylated integrin quantified by ELISA as for internalization. In this
way, total biotinylated internalized integrinwas quantified at time 0, and the
fraction remaining inside measured at the various time points. From this
value, the amount of recycled integrin could be expressed as a percentage of
total internalized integrin.
Results
Our experiments focus on 91 integrin, as in our previous
work, because of its relevance to axon regeneration in the spinal
cord. We use two models, adult rat DRG axons and PC12 cells.
PC12 cells have been used for experiments on integrin internal-
ization and recycling, which cannot be performed in primary
DRG cultures, while most axon growth and axonal transport
assays have been performed in adult DRG neurons. We obtained
congruent results from the two cell types. Using these cell types it
is possible to perform integrin-dependent growth assays, because
neither DRG axons nor PC12 cell neurites will grow on tenascin
surfaces unless they are transfected with 9. Our experiments
focus on both1 and9 integrins; the1 subunit is expressed by
both cell types, allowing for more complex experiments on an
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endogenous integrin. To study the role of ARF6 in integrin trans-
port, internalization, and recycling we have used a number of
ARF6-related constructs. To aid comprehension of the experi-
ments, these constructs have been summarized in Table 1.
Does ARF6 colocalize with integrin in axons and
growth cones?
We first asked whether endogenous ARF6 colocalized with integ-
rins in the axons and growth cones of adult DRG neurons, focus-
ing on endogenous 1 integrin while performing additional
experiments with PC12 cells stably expressing 9 integrin. Using
1 integrin and ARF6 immunocytochemistry, we found partial
overlap between the two proteins at the growth cones and axons
of adult DRGs in distinct regions of the growth cone (Fig. 1A,
triangle) and in vesicular structures (arrows). To confirm this
result we used epitope-tagged wt and mutant ARF6 constructs,
which are well established tools used for investigating ARF6 dis-
tribution (Donaldson, 2003; Gillingham and Munro, 2007).
Adult DRG neurons were transfected with HA-tagged wt ARF6,
dominant inactive ARF6 (ARF6-T27N), or constitutively active
ARF6-Q67L, all of which partially colocalized with 1 integrin at
the growth cone (Fig. 1B–D). We found overlap between wt-
ARF6-HA and 1 integrin in filopodia (Fig. 1B, dotted lines), as
well as in distinct structures such as the curved tubular structure
magnified in Figure 1B, and in vesicles (arrows). Dominant-
negative ARF6-T27N expression resulted in prominent 1 integ-
rin fluorescence at the growth cone periphery where the two
proteins colocalized (Fig. 1C, dotted lines), and we also found
colocalization in vesicular structures inside the growth cone (ar-
rows). Expression of constitutively active ARF6-Q67L is known
to cause enlarged endosomal structures containing ARF6-
regulated membrane constituents (Brown et al., 2001; Aikawa
and Martin, 2003; Naslavsky et al., 2003; Sannerud et al., 2011).
We found that ARF6-Q67L expression generated enlarged endo-
somal structures that were positive for both ARF6-Q67L and 1
integrin throughout adult DRG neurons, including at the cell
body (data not shown) and growth cone where vacuolar struc-
tures were found aggregating in the central domain (Fig. 1D, oval
region). These enlarged structures were also present in the axons
of ARF6-Q67L transfected cells (Fig. 1E), but not in the axons of
wt or ARF6-T27N transfected cells. Colocalization was also ob-
served in vesicular structures of more normal appearance (Fig.
1D, arrow). These experiments were also performed in differen-
tiated PC12 cells (both wt and stably expressing 9) where we
found similar overlap of both1 and9 integrinwithARF6 (data
not shown).We also confirmed that endogenous ARF6 is present
in an endosomal fraction, using vesicles purified from differenti-
ated PC12 cells by a protocol that we have previously used to
investigate integrin and Rab11 distribution (Eva et al., 2010).
Subcellular fractionation was used to divide vesicular structures
into eight pools, fractions 4 and 5 corresponding to endosomes.
We found that ARF6, 1 integrins, and Rab11 were all enriched
in these endosomal fractions (Fig. 1F). Together these data sug-
gest that integrins are present in ARF6 vesicles, suggesting the
possibility that ARF6 is involved in the trafficking of 1 integrins
in axons and growth cones.
Are integrins rapidly transported over long distances via
ARF6-positive endosomes?
We previously found that a population of vesicles containing 9
integrin are transported rapidly over long distances along neu-
rites, exiting the Rab11 compartment as they begin rapid move-
ment (Eva et al., 2010). We wondered if these fast-moving
structures are associated with ARF6 during their periods of rapid
movement. To address this we tried live imaging of ARF6-GFP,
but found that it localized unexpectedly to large amorphous
blobs. Other researchers have found that ARF6-GFP does not
always localize as expected (Hall et al., 2008), so we turned to a
SNAP tag as an alternative. This is a nonfluorescent monomeric
protein tag that can be visualized in live cells with membrane-
permeable dyes that bind irreversibly and covalently to the tag.
We first generated PC12 cells stably expressing ARF6-SNAP then
live-labeled the cells with a red fluorescent dye, followed by ap-
plication of green anti-1 integrin-Alexa 488, which internalizes
attached to 1 integrin. ARF6-SNAP localized to the cell mem-
brane and vesicular structures, and internalized 1–488 colocal-
ized with these vesicles (Fig. 2A). We confirmed the specificity of
the dye by using a nonfluorescent variant to block the tag before
addition of the dye (data not shown). We then investigated the
dynamics of ARF6-SNAP in the neurites of differentiated PC12
cells using spinning disk confocalmicroscopy, and quantified the
instantaneous velocity and distance traveled by ARF6-SNAP ves-
icles. We found that the majority of ARF6 vesicles were fast mov-
ing, traveling at a velocity of 1–2 m/s with the majority of
vesicles covering 2–12m/30 s (Fig. 2B). This is a similar velocity
to the population of rapidlymoving Rab11-negative9-GFP ves-
icles, which we previously found to move at a velocity between 1
and 3m/s, covering distances of 0.2m/30 s–10.4m/30 s (Eva
et al., 2010).We asked whether endogenous integrins were trans-
ported in these vesicles. To address this, we live labeled the cells
with anti1-Alexa 488, which allows visualization of cell-surface
integrins as well as internalized integrins in vesicular structures.
The dye-labeled ARF6-SNAP bleached rapidly, making these ex-
periments technically challenging; however, we found ARF6-
SNAP and 1–488 moving in concert in rapidly moving vesicles
(Fig. 2C,D, kymograph). We also observed ARF6-SNAP and 9-
GFP moving similarly anterogradely along neurites (data not
shown). These data demonstrate that ARF6 moves rapidly long
distances in neurites, colocalizing with 91 integrin during
rapid transport toward the growth cone.
Can ARF6 expression and activity be modulated to enhance
integrin-dependent neurite outgrowth?
Our main aim is to enhance integrin-dependent axon regeneration
after injury, so we next examined whether we could manipulate
ARF6 expression and activity to enhance integrin-dependent axon
growth. To address this, we used the 9 integrin specific outgrowth
assay that we have described previously (Eva et al., 2010), in which
NGF-stimulatedPC12cellswillonlygrowprocessesonasubstrateof
tenascin if they express 9 integrin. PC12 cells stably expressing 9
were plated onto tenascin-C. To confirm the role of 9 in process
outgrowth some cultureswere treatedwith an9 blocking antibody
Table 1. Summary of ARF6-related constructs used for investigating the role of
ARF6 in integrin-dependent neurite outgrowth and integrin transport,
internalization and recycling
ARF6 wild-type Tagged with a SNAP tag or HA for recognition
ARF6-T27N Dominant-negative ARF6
ARF6-Q67L Constitutively active ARF6
ACAP1 ARF6 GAP, increases ARF6-GDP (inactivation)
Also acts as a coat protein
ACAP1-R448Q Dominant-negative GAP-dead mutant
Still functions as a coat protein
EFA6 ARF6 GEF, increases ARF6-GTP (activation)
ARNO ARF6 GEF increases ARF6-GTP (activation)
HA, hemagglutinin.
Eva et al. • Integrins Traffic Via ARF6 in Axons J. Neurosci., July 25, 2012 • 32(30):10352–10364 • 10355
at a concentration that approximately
halves outgrowth length (Fig. 3). We ma-
nipulated ARF6 activity using either an
ARF6GAP (inactivator) orGEF (activator),
or by overexpressing wt ARF6. This ap-
proach mimics the control of ARF6 in vivo
(as it has very low intrinsic GTPase activity,
and almost totally relies on its GEFs and
GAPs for control of its function) (Gilling-
ham and Munro, 2007). Manipulation of
ARF6 functionwithGAPsandGEFs ismore
physiological and less forceful than using
ARF6 constructs locked in either the active
GTP-bound form or inactive GDP-bound
form (since ARF6 regulates many cellular
functions by cycling between these two
states) (Brown et al., 2001; Donaldson,
2003). Overexpression of ARF6 did not sig-
nificantly affect process outgrowth (Fig.
3A,B; p  0.05). ACAP1 is an ARF6 GAP
that has been reported tomediate 1 integ-
rin recycling in non-neuronal cells, acting
either through its ARF6 GAP activity or ad-
ditionally by acting as a coat protein (Jack-
son et al., 2000; Dai et al., 2004; Li et al.,
2005, 2007b). Overexpression of ACAP1
substantially increased outgrowth (from
315 to 426 m), while expression of GAP
deadACAP1R448Q (amutant ACAP1 that
has no GAP activity but still functions as a
coat protein) reduced outgrowth (to 278
m). In both cases, outgrowth was further
reduced in the presence of the blocking an-
tibody. This suggests that ACAP1 promotes
integrin-dependent outgrowth, functioning
through itsARF6GAPactivity andnotby its
function as a coat protein. We next investi-
gated the effects of activating ARF6 using
two ARF6 GEFs that are expressed in neu-
rons, EFA6 (Sakagami, 2008) and ARNO
(Herna´ndez-Deviez et al., 2002, 2004, 2007;
Herna´ndez-Deviez and Wilson, 2005).
EFA6 has ARF6-specific GEF activity
(Franco et al., 1999; Macia et al., 2001),
whileARNOis reported tohave someARF1
GEF activity in vitro, but is considered to be
principally anARF6GEF (Frank et al., 1998;
Venkateswarlu and Cullen, 2000; Macia et
al., 2001; Gillingham and Munro, 2007;
Hofmann et al., 2007). Expression of either
ARNO or EFA6 resulted in a substantial in-
hibition of neurite outgrowth (to 143 and
207m, respectively),whichwas further re-
duced in the presence of the blocking anti-
body (Fig. 3A,B). These data show that
ARF6 GEFs inhibit integrin-dependent
neurite outgrowth, in contrast to the ARF6
GAP ACAP1, which enhances it.
Does modulation of ARF6 activity affect axon growth from
adult DRG neurons?
Having demonstrated an effect of ARF6modulation on integrin-
dependent outgrowth by PC12 cells, we asked whether axon
growth from adult DRG neurons could also be enhanced. We
therefore transfected dissociatedDRGneurons, before plating on
laminin with ACAP1, ACAP1 R448Q, ARNO, EFA6, or GFP as a
control, andmeasured axon length after 2 d in culture.We found
that ACAP1 expression increased axon length compared with
Figure 1. ARF6 regulates1 integrin localization in DRG axons and growth cones. Images are axons and growth cones of adult
DRG neurons. ARF6 and1 integrins partly colocalize in distinct regions (triangle) and vesicular structures (arrows) (A, maximum
projection and single confocal section inset). Overlap is also present after expression of wt ARF6-HA in growth cone vesicles (B,
arrows; inset is a single confocal section) and filopodia (B, dotted lines). Expression of dominant-negative ARF6 T27N leads to
prominent1 integrin localizationat thegrowth coneperiphery,where the twoproteins colocalize (C, dotted lines). Colocalization
is also evident in vesicles (C, arrows; inset is a single confocal section). Expression of constitutively active ARF6 Q67L results in
accumulation of ARF6 in swollen intracellular structures within the growth cone, which also label for1 integrin (D, circled), and
colocalization is also apparent at vesicular structures of more usual size (D, arrows). Swollen vesicles containing ARF6 and 1
integrin were also present in DRG axons (E, inset is a single confocal section). Subcellular fractionation confirmed that ARF6 is
enriched in the endosomal fraction (fraction 5) inmaturely differentiated PC12 cells, as is1 integrin andRab11 (F ). Scale bars: 10
m. A–C and E are maximum projections with a single confocal slice magnified in the inset. D is a single confocal section.
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GFP-expressing controls (from 415 to 526 m), and that EFA6
and ARNO both substantially inhibited axon growth (243 and
227 m, respectively). EFA6-transfected cells had two pheno-
types: one with short axons with a normal morphology, and one
with abnormal neurite stubs that ap-
peared bunched and branchy; however,
there were no statistical differences in the
number of neurites or branch points of
these or any other axons compared with
control cells.
Expression of ACAP1 R448Q also led
to a reduction in axon length, but to a
lesser extent (342 m) (Fig. 4). This sug-
gests that ACAP1 overexpression en-
hances axon growth, via amechanism that
includes its GAP activity. These findings
are similar to the results of our PC12 9
integrin-dependent outgrowth assay, and
suggest that ARF6 is involved in regulat-
ing axon growth in sensory neurons, at
least in part, through an integrin-related
effect.
Does modulation of ARF6 activity
affect endocytosis or recycling of
1 integrins?
We wanted to establish if the effects on
integrin-dependent outgrowth caused by
ARF6 manipulation were associated with
altered trafficking of integrins. ARF6 is
involved in a number of trafficking pro-
cesses, including internalization of mem-
brane proteins from the cell surface
(Naslavsky et al., 2004; Dunphy et al.,
2006; Gong et al., 2007; Lavezzari and
Roche, 2007), recycling of membrane
proteins (Radhakrishna et al., 1996; Pow-
elka et al., 2004; Barral et al., 2008; Yu et
al., 2011), and transport along microtu-
bules (Caplan et al., 2002; Kanamarla-
pudi, 2005; Balasubramanian et al., 2007;
Montagnac et al., 2009, 2011). To address
these issues we quantified the effects of
increasing or decreasing ARF6 activa-
tion by overexpressing ACAP1, EFA6, or
ARNO on integrin internalization and re-
cycling.Here,1 integrinwas investigated
as it is expressed endogenously, allowing
for results that would not be affected by
overexpression of an integrin. To quantify
1 integrin internalization we used an es-
tablished capture-ELISA protocol (Rob-
erts et al., 2001; Pellinen et al., 2006;
Arjonen et al., 2012). Briefly, this involves
biotinylation of the cell surface at 4°C, fol-
lowed by 30 min incubation at 37°C, to
restart trafficking and allow intracellular
accumulation of biotinylated surface in-
tegrins. Cell-surface biotin is then re-
moved at 4°C using a reduction buffer, so
that only internalized biotin remains. The
control is cells from which surface biotin
has not been cleaved so that internalized
biotinylated integrin can be expressed as a percentage of total
biotinylated integrin. Lysed cell contents are assayed for biotin-
ylated integrin using ELISA plates coated with 1 integrin
antibodies.
Figure 2. ARF6 vesicles are transported rapidly and contain1 integrins. SNAP-tagged ARF6 (red) colocalizes with internalized1
integrins (green) in PC12 cells live labeled with anti-1–488, and subsequently fixed and imaged by confocal microscopy (A). Images
shownareorthogonal viewsof a z-stack indicatingvesicular colocalization, Scalebar, 10m.Spinningdisk confocalmicroscopywasused
to image maturely differentiated PC12 cells stably expressing ARF6-SNAP, and vesicle dynamics were quantified by tracking individual
vesicles in neurites (B). Vesicles were tracked for their visible lifetime and the instantaneous velocity was calculated from themaximum
distance moved by a vesicle between two frames (3 s). Maximum net movement over 10 frames is a measure of the furthest a vesicle
traveledfromitsoriginover30s.Anterogradeandretrogrademovementswereincludedintheanalysis.ARF6-SNAPmovementisrapidand
occurs over long distances. Differentiated PC12 cells stably expressing ARF6-SNAP were live labeled with anti-1–488 and imaged by
spinningdiskconfocalmicroscopy.ARF6-SNAPvesiclesdual labeledfor1integrinwereobservedmovinganterogradelyandretrogradely,
and are shownhere arriving at the growth cone (C). Arrows indicate a two-colored vesiclemoving anterogradely. The rapidmovement of
thisARF6/1integrin-positivevesicle is indicatedbythegentleslopedisplayedonakymograph(D,arrows),whichalsodisplaysaveryslow
moving structure (the very steep yellow line).
Eva et al. • Integrins Traffic Via ARF6 in Axons J. Neurosci., July 25, 2012 • 32(30):10352–10364 • 10357
We used the capture ELISA on ma-
turely differentiated PC12 cells that had
been transiently transfected to overex-
press the ARF6 regulatory proteins and
mock transfected controls. These cells ex-
hibit large neuronal cell bodies and well
established neurites and growth cones
(Fig. 5D). Cells were transfected with the
same amount of DNA, and all the con-
structs were under the control of the same
promoter. We estimated that they were
expressing similar amounts of protein by
performingWestern blots on the lysates of
transfected cells (Fig. 5C). We also quan-
tified the transfection efficiency of the
cells transfected with GFP-tagged con-
structs before each experiment. The effi-
ciency was typically 70–80%. We found
that inactivation of ARF6 with the ARF
GAP ACAP1 had no effect on the amount
of 1 integrin that was internalized from
the cell surface 30 min (Fig. 5A, p 
0.05), but that overexpression of the GAP
dead ACAP1-R448Qmutant resulted in a
significant increase in internalized 1 in-
tegrin compared with mock transfected
controls (from 21 to 31%, p  0.01). Ac-
tivation of ARF6 by overexpression of ei-
ther of the ARF GEFs, EFA6 or ARNO,
also greatly increased integrin endocytosis
(37 and 38%, respectively, p 0.001; Fig.
5A). This would suggest that ACAP1
R448Q is acting as a dominant-negative
ACAP1 with respect to 1 integrin inter-
nalization (behaving similarly to two
ARF6GEFs). Together, the results suggest
that activation of ARF6 leads to an ele-
vated 1 integrin internalization rate.
We next used the same capture ELISA
protocol to quantify 1 integrin recycling
back to the cell surface. This can be done
by allowing internalization to occur for 30
min and measuring the quantity of inter-
nalized 1 integrins as a total internalized
pool. In parallel cultures, recycling is al-
lowed to occur at 37°C for various periods
of time and surface biotin is once again
removed at 4°C. After lysis, the amount of
biotinylated integrin remaining in the
cells is expressed as a percentage of the
total internalized pool so that the amount
of recycled integrin can be calculated. We
were surprised to find that internalized1
integrins recycled extremely rapidly, and
that after 5 min39% of internalized 1
integrins had been recycled in control
cells, and that by 10 min re-internalization
was already occurring (Fig. 5B). Overex-
pressionof the inactivatingGAPACAP1 led
to a substantial increase in recycling com-
pared with the controls, with 62% (p 
0.05) being recycled to the cell surface
within5min.ACAP1-R448Qalso increased
Figure 3. Manipulation of ARF6 regulates 9 integrin-dependent neurite outgrowth on tenascin. Differentiated PC12
cells stably expressing 9 integrin were trypsinized and electroporated with ARF6 regulatory proteins: ARF6 GEFs, either
ARNO or EFA6, an ARF6 GAP, ACAP1, mutant ACAP1 R448Q lacking GAP activity, or wt ARF6 as indicated or mock transfected
as a control. These were then grown on a substrate of tenascin for 2 d, in the presence or absence of an 91 blocking
antibody (at a concentration that partly inhibits growth), and analyzed for maximum neurite length. Representative
images are shown of each condition (A). Scale bar, 100m. Overexpression of ACAP1 increases9-dependent outgrowth,
which is inhibited by anti-91, whereas ACAP1 R448Q expression inhibits outgrowth, which is inhibited further by
anti-91. Both EFA6 and ARNO inhibit 9-dependent outgrowth (ARNO expression results in the most marked effects)
and outgrowth is inhibited further by addition of anti-91. Expression of full-length ARF6 had no effect (B). Data were
analyzed using ANOVA followed by post hoc analysis. In all cases, blocking with anti-91 causes statistically significant
changes ( p 0.001). Error bars indicate SEM.
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recycling, althoughnot significantly (53%,p0.05), suggesting that
ACAP1 is functioningmostly through its ARFGAPactivity, but also
partly as a coat protein independently of this. In contrast, expression
of either of the activatingGEFs, EFA6orARNO,hadnoeffect on the
rate of recycling (p 0.05); however, there
was a nonsignificant increase in the rate at
which 1 integrins were internalized by 15
min. Together, these data suggest that inac-
tivation of ARF6 increases the rate at which
1 integrins are recycled to the cell surface.
Does modulation of ARF6 activity affect
axonal transport of9 integrin?
ARF6 is implicated in the trafficking of
membrane proteins in vesicles along mi-
crotubules (Caplan et al., 2002; Kanamar-
lapudi, 2005; Balasubramanian et al.,
2007; Montagnac et al., 2009, 2011). It is
linked to motor proteins via the scaffold
molecules JIP3 and JIP4, and its activation
state governs the affinity of the JIP mole-
cules for either kinesin motor proteins or
the dynactin/dynein complex, such that
ARF6-GTP (activated) interferes with
JIP’s association with kinesin motors, in-
creasing the affinity of the JIP molecules
for the dynactin complex (Isabet et al.,
2009; Montagnac et al., 2009, 2011;
Suzuki et al., 2010). Given the polarized
nature of microtubules in axons (Baas et
al., 1988), we hypothesized that activation
of ARF6 by overexpression of ARF6 GEFs
might lead to increased retrograde trans-
port, while inactivation of ARF6would fa-
vor anterograde transport of integrins. To
address this, we used spinning disk confo-
cal microscopy to capture images of 9
integrin-GFP being transported in adult
DRG axons coexpressing ARF6 regulatory
proteins, and quantified the velocity and
direction of 9-GFP vesicles. We used the
Cellaxess in-dish electroporator to cotrans-
fect the cells once axon growth was estab-
lished, and found that 100% of cells
expressing 9-GFP also expressed the
cotransfected construct (after fixation and
antibody labeling). This allowedus to image
9-GFP assuming the presence in that cell
of the unlabeled cotransfectant. All cells
were fixed and labeled after the experiments
to ensure that the cotransfected construct
was expressed (Fig. 6A). To quantify the di-
rection of transport, we classed vesicles as
immobile, retrograde, anterograde, or bidi-
rectional. We found that expression of the
ARF6 regulatory proteins had no effect on
theproportionofmobile and immobile ves-
icles (Fig. 6B; p  0.05), but that they did
affect the direction traveled by moving ves-
icles. Expression of the inactivating GAP
ACAP1increased theproportionof9-GFP
vesiclesmovinganterograde comparedwith
controls (from 31 to 46%), and decreased
the retrograde fraction from 35 to 21% (Fig. 6C). ACAP1 R448Q
again appeared to function as a dominant-negative, and its expres-
sion led to a substantial increase in retrograde transport of 9-GFP
(54% of themobile fraction), accompanied by a decrease in antero-
Figure 4. Manipulation of ARF6 affects axon growth in adult DRG neurons. Representative images of DRG neurons expressing
ARF6 regulatory proteins as indicated (A). Expression of ACAP1 in adult DRG neurons increases axon growth after 2 d in standard
culture conditions, while expression of GAP dead ACAP1 R448Q decreases axon growth. Expression of either EFA6 or ARNO (ARF6
GEFs) leads to a substantial reduction in DRG axon growth (B). Data were analyzed by ANOVAwith post hoc analysis. p 0.001 in
all cases, compared with GFP-expressing controls. Scale bar, 100m.
Figure 5. Manipulation of ARF6 activity regulates 1 integrin internalization and recycling. 1 integrin endocytosis and
recycling were measured using a surface biotinylation protocol (described in detail in Materials and Methods) on maturely differ-
entiated PC12 cells transfected with ARF6 regulatory proteins as indicated or mock transfected control cells. Integrin endocytosis
was allowed to occur for 30 min, and internalized1 integrin quantified by ELISA. Expression of the ARF6 GEFS ARNO and EFA6
increases1 integrin internalization compared with mock transfected controls, while expression of GAP dead ACAP1 R448Q also
increases internalization to a lesser extent. Expression of the ARF6 GAP ACAP1 has no effect (A). Integrin endocytosis was once
again allowed to occur for 30min, this time followedby removal of surface integrins, and subsequent incubation to allow recycling
to occur for the time points indicated. ACAP1 expression resulted in a significant increase in the rate of 1 integrin recycling
compared with controls ( p 0.05), while ACAP1 R448Q increased recycling to a lesser extent, although this did not achieve
significance ( p 0.05). Expression of ARNO and EFA6 had no effect on the rate of recycling, but appeared to increase the rate of
internalization of rapidly recycled integrins compared with controls, although again this was not significant (B). Transfected cells
were lysed and examined by Western blot to check for expression of the transfected constructs (C). All extracts were run on the
sameblot, and then separated for antibody labeling, and reunited for simultaneous developing.D is a representative image of 12 d
differentiated PC12 cells to highlight the neuronal morphology of the cells at the time of experimentation. Scale bar, 100m.
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Figure6. ARF6manipulation regulates the direction of9 integrin axonal transport. Spinning disk confocalmicroscopywas used to image adult DRGneurons expressing9 integrin-GFP, either
alone or cotransfected with epitope-tagged ARF6 regulatory proteins. Cotransfection was confirmed after imaging by fixing and antibody labeling. One hundred percent of cotransfected neurons
expressing 9-GFP also expressed their cotransfected partners. Dissociated adult DRG cultures were transfected with 9-GFP alone, and 9-GFP with either ACAP1-myc, ACAP1 R448Q FLAG,
ARNO-FLAG, or EFA6-FLAG (A). Images of9-GFP in DRG axons were acquired for 5 min, capturing frames every 3 s. These were used to generate movies and kymographs (E). Vesicles were then
tracked for their visible lifetime usingMetaMorph software and analyzed to quantify direction and velocity. None of the constructs expressed altered the balance between themobile and immobile
fraction of9-GFP vesicles (B); however, differenceswere seen between the proportion of anterograde and retrograde vesicleswithin themobile fraction. Coexpression of (Figure legend continues.)
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grade transport to 23% (Fig. 6C). Expression of either of the activat-
ing GEFs, ARNO or EFA6, also led to an increase in retrograde
transport (43 and 48%, respectively; Fig. 6C). The proportion of
vesicles moving bidirectionally was not changed by any of the mol-
ecules (Fig. 6C; p 0.05). Quantification of the maximum instan-
taneous velocity or average velocity of moving 9-GFP vesicles
showedno statistical difference between any of the groups, although
there was a trend for ARNO expression leading to slower antero-
grade movement and faster retrograde movement compared with
control cells (Fig. 6D); the effect of modulating ARF6 function is
therefore on the direction of transport rather than its velocity. These
data suggest that inactivationofARF6 increases theanterograde flow
of 9-integrins, while activation of ARF6 leads to more retrograde
axonal transport, and this is highlighted by representative kymo-
graph images that were generated frommovie stack files (Fig. 6E).
Discussion
We have previously described a strategy to increase axon regen-
eration after injury via exogenous introduction of 9 integrin,
enabling axons to interact with the extracellularmatrix glycopro-
tein tenascin-C, which is upregulated after injury (Andrews et al.,
2009). While this strategy works dramatically in vitro, imple-
menting it in vivo has revealed that inhibitory molecules in the
CNS inactivate integrins (Tan et al., 2011), and that integrin
transport into some CNS axons is limited (J. W. Fawcett and
M. R. Andrews, unpublished results). We are therefore investi-
gating strategies for enhancing integrin-dependent axon growth
focusing on promoting integrin activation (Tan et al., 2011) and
trafficking (Eva et al., 2010). We also believe that a full under-
standing of successful integrin-mediated axon growth will allow
us to identify fundamental defects that prevent regeneration in
CNS axons. In our previous trafficking study, we found that
much of the 1 integrin within axons is in vesicles marked by
Rab11. We also demonstrated that Rab11 and its effector Rab
coupling protein could be used as tools to enhance integrin-
dependent outgrowth (Eva et al., 2010). Rab11 vesicles exhibited
principally localizedmovement, andwhen integrins traveled rap-
idly over larger distances they exited the Rab11 compartment,
re-entering it when they ceased rapid transport. This suggests that
other molecules are involved in this rapid long-range transport,
the manipulation of which might provide strategies for promot-
ing regeneration. A further integrin trafficking pathway regulated
by ARF6 has been described in non-neuronal cells (Pellinen and
Ivaska, 2006). ARF6-dependent transport is along microtubules,
driven by kinesin motors (as opposed to Rab11-dependent traf-
ficking, which is slow and reportedly moves via myosin motors)
(Li et al., 2007a; Wang et al., 2008; Eva et al., 2010; Schuh, 2011).
The intention of this study was to investigate the hypothesis that
integrinsmight transport rapidly in ARF6 vesicles, and that ARF6
might be involved in integrin trafficking in growth cones. Our
experiments support this hypothesis. We have established that
there is an integrin trafficking pathway in adult DRG axons, ad-
ditional to the Rab11 pathway that we have already described,
that is regulated by ARF6. This pathway is responsible for rapid
integrin transport. Importantly, this pathway can be manipu-
lated to enhance integrin-dependent axon growth. Promoting
inactivation of ARF6 by expressing an ARF6 GAP increases axon
growth, while activation by expression of ARF6 GEFs leads to
reduced growth. These changes accompany altered rates of integ-
rin endocytosis and recycling, as well as axon transport, also reg-
ulated by the ARF6 activation state.
Integrins traffic via ARF6 in adult DRG axons
Using ARF6 antibodies as well as mutant ARF6 proteins, we have
found that ARF6 is present in adult DRG axons and growth
cones, where it is involved in trafficking of 1 integrins. Live cell
imaging has revealed that integrin in ARF6 vesicles is transported
rapidly both anterogradely and retrogradely. This is in addition
to the Rab11-dependent trafficking of integrins that we had pre-
viously described. ARF6 and Rab11 share certain effector pro-
teins and cooperate during cytokinesis (Hickson et al., 2003;
Fielding et al., 2005), and we have now found that the two mol-
ecules also cooperate in the axonal trafficking of integrins, with
distinctions in the way that vesicles marked by the two proteins
traffic. ARF6marks rapidly moving vesicles, while Rab11 vesicles
show small localized movements. We have previously observed
fast-moving integrins pausing in Rab11 domains. This could be
due to shuttling of integrins between compartments, or swapping
of the GTPases on integrin vesicles. This could be governed by
localized signaling molecules that regulate the activity of GAP
and GEF proteins, such as the PI3 kinase/AKT pathway (Ven-
kateswarlu andCullen, 2000; Li et al., 2005) or interactions driven
by the presence of shared effector molecules (Horgan and
McCaffrey, 2009).
Themajority of classical axonal transport as driven by kinesin
or dynein motors along microtubules travels at a similar speed
(1–2 m/s) to ARF6-positive vesicles, and ARF6 is known to
traffic along microtubules (Balasubramanian et al., 2007). It has
recently come to light that Rab11 contributes to long-range
movement via a novel actin-dependent and microtubule-
independent mechanism, reliant on myosin motors (Schuh,
2011). This has yet to be confirmed in axons; however, it will be
interesting to determine whether there are two pathways for ax-
onal transport, either by slow actin-based movement or by rapid
microtubule-dependent transport.
We have investigated integrin traffic in regenerating adult pe-
ripheral sensory axons that have a good regenerative potential.
These may differ from mature CNS axons, and it is unclear how
ARF6 localizes within mature CNS neurons in vivo. There is evi-
dence that ARF6 influences developing CNS processes because
manipulation of the ARF6 GEF, ARNO, results in altered den-
dritic and axonal morphology of cultured hippocampal neurons
(Herna´ndez-Deviez et al., 2004; Herna´ndez-Deviez and Wilson,
2005), and because interfering with the ARF6-JIP3 interaction
affects axon length in cortical neurons (Suzuki et al., 2010). Fu-
ture work will investigate whether there is a trafficking role for
ARF6 in mature CNS axons, or whether it is mainly restricted to
the somatodendritic compartment. ARF6 is involved in a num-
ber of postsynaptic functions within dendritic spines (Choi et al.,
2006; Sakagami et al., 2008; Scholz et al., 2010; Fukaya et al.,
2011), and is reported to be largely absent from axons of mature
hippocampal neurons in culture (Sannerud et al., 2011); how-
ever, it is also reported to function presynaptically (Ashery et al.,
4
(Figure legend continued.) ACAP1 led to an increase in the proportion of anterogrademove-
ment and a decrease in retrogrademovement,while ACAP1R448Q expression had the opposite
effect. Expression of EFA6 andARNO increased retrograde transport and decreased anterograde
transport. No statistical changes were found for the bidirectional fraction (C; p 0.05). Data
were analyzed by ANOVAwith post hoc analysis. Analysis of instantaneous and average velocity
revealed only small differences between groups (D). Cumulative frequency distributions were
plotted for anterograde (D, left), and retrograde (D, right) instantaneous and average velocity,
and analyzed using a Kruskal–Wallis test for variance. While no statistical differences were
found, there was a trend for ARNO expression leading to slower anterograde transport and
faster retrograde transport compared with controls (D; ARNO, purple lines; control, light blue
lines). Scale bars: A, 100m; E, 5m.
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1999; Krauss et al., 2003), which might indicate that there is a
population of ARF6-positive vesicles trafficking within some
adult CNS axons.
ARF6 and integrin-dependent neurite outgrowth
We have found that ARF6 can be manipulated to enhance
integrin-dependent neurite outgrowth. ARF6 has little intrinsic
GTPase activity, and is reliant on its GEFs and GAPs for its reg-
ulation (GillinghamandMunro, 2007). The level of expression of
these ARF6 regulatory proteins impacts integrin-dependent
growth in PC12 cells and in DRG neurons, with inactivation of
ARF6 by overexpression of a GAP, ACAP1, enhancing out-
growth, while expression of two ARF6-activating GEFs leads to
decreased outgrowth. This is in keeping with previous findings in
neurons, as expression of either a mutant ARNO that lacks GEF
activity or a dominant-negative ARF6 leads to an increase in axon
length in hippocampal cultures (Herna´ndez-Deviez et al., 2004),
while a mutant p95-APP1 (an ARF6 GAP) lacking the GAP do-
main inhibits neuritogenesis (Albertinazzi et al., 2003). EFA6 is
also reported to oppose axon regeneration in Caenorhabditis el-
egans, although thismay be functioning independently of its ARF
GEF activity (Chen et al., 2011).
Interfering with Rab11 also inhibits axon extension (Eva et al.,
2010). Correct function of both Rab11 and ARF6 is therefore
required for optimal axonal growth, and it is possible that the two
molecules may cooperate in regulating it. It will be important to
determine whether there is a developmentally regulated mecha-
nism to regulate ARF6 and/or Rab11 in adult CNS axons that
might limit integrin-dependent axonal regeneration after injury.
ARF6 and integrin recycling
ARF6 is involved in 1 integrin recycling in non-neuronal cells
(Powelka et al., 2004;Dunphy et al., 2006; Yu et al., 2011; Arjonen
et al., 2012), and we have now found that 1 integrin internaliza-
tion and recycling back to the cell surface are affected by overex-
pression of ARF6 regulatory proteins in differentiated PC12 cells.
Expressing the ARF6 GEFs, ARNO and EFA6, increases the rate
of integrin internalization from the surface, but ACAP1 expres-
sion does not oppose this. However, ACAP1 overexpression in-
creases the rate of recycling to the surface, which is unaffected by
expression of the two GEFs. ACAP1 functionsmainly through its
GAP activity to increase the rate of recycling, but also as a coat
protein independently of this (asmutating theGAPdomain leads
to a smaller increase in the rate of recycling). It would therefore
appear that activating ARF6 increases the rate of 1 integrin in-
ternalization, contributing to a decrease in integrin-dependent
neurite outgrowth. On the other hand, inactivating ARF6 in-
creases the rate of 1 integrin recycling allowing for greater
integrin-dependent outgrowth. These results must also be con-
sidered in addition to our findings regarding the effects of ARF6
manipulation on the direction of axon transport.
ARF6 and axon transport
We are particularly interested in understanding how integrin en-
try to the axon is regulated, as we find that integrins are not
transported efficiently into certain adult CNS neurons (Andrews
et al., unpublished observations). Our finding in this paper that
ARF6 activation can bemanipulated to regulate the overall direc-
tion of integrin transport within the axon may be relevant to this
observation. Expression of EFA6 or ARNO increased retrograde
transport while decreasing anterograde transport, and conversely
ARF6 inactivation by expression of ACAP1 led to an increase in
anterograde transport and a decrease in retrograde movement.
Approximately a third of9-GFP vesiclesmove bidirectionally in
control axons, and even vesicles with net anterograde or retro-
grade movement usually show occasional short reverses to the
other direction. These direction changes may indicate that ARF6
activation is dynamic, depending on the local preponderance of
GAPs and GEFs.
Our results establish a role for ARF6 in the regulation of in-
tegrin traffic in peripheral neurons and demonstrate that ARF6
trafficking can be manipulated through ARF6 GAPs and GEFs to
regulate the recycling of integrins and the direction of integrin
transport within the axon, leading to changes in integrin-
dependent growth. Future experiments will determine whether
other molecules involved in axon regeneration are similarly
transported, and whether enhanced axon regeneration after in-
jury can be achieved through targeting ARF6.
Notes
Supplemental material for this article is available at http://www.brc.cam.
ac.uk/principal-investigators/james-fawcett/recent-papers/. This mate-
rial has not been peer reviewed.
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